Suppr超能文献

小蛋白LINC01547-ORF通过调节CLDN18-FAK-AKT轴抑制结直肠癌进展。

The small protein LINC01547-ORF inhibits colorectal cancer progression by regulating the CLDN18-FAK-AKT axis.

作者信息

Zhang Shuai, Xu Siguang, Li Dandan, Wu Songxin, Han Miaomiao, Han Yifei, Wang Zixi, Qiao Dan, Yuan Hang, Du Baoshun, Chen Hongwei, Zhang Zheying

机构信息

Department of Pathology, School of Basic Medical Sciences, Xinxiang Medical University Xinxiang 453003, Henan, China.

Department of Emergency Center Emergency Critical Care, The Fourth Clinical College of Xinxiang Medical College Xinxiang 453003, Henan, China.

出版信息

Am J Cancer Res. 2024 Nov 15;14(11):5504-5520. doi: 10.62347/PNKH7683. eCollection 2024.

Abstract

Long non-coding RNA (lncRNA)-encoded small proteins play a major role in colorectal cancer. To identify more functional encoded small proteins, ribosome profiling data from colorectal cancer (CRC) cells were screened for ribosome-associated lncRNAs. The search identified LINC01547 that was shown to encode a small protein of 76 amino acids, termed LINC01547-ORF. Real-time quantitative fluorescence showed that LINC01547 expression was downregulated in colorectal cancer tissues. However, cell functional assays revealed that LINC01547 inhibited the proliferation and migration of colorectal cancer cell lines. Meanwhile, western blot and immunofluorescence assays confirmed that LINC01547 encoded LINC01547-ORF. Cellular functional assays indicated that compared with LINC01547 itself, LINC01547-ORF inhibited the proliferation and migration of colorectal cancer cell lines. Gene set enrichment analysis identified enrichment in the focal adhesion pathway and association with CLDN18 protein, whereas protein molecular docking models revealed interacting domains and amino acid residue sites. Of note, co-immunoprecipitation and immunofluorescence experiments showed that LINC01547-ORF could bind to the CLDN18 protein and that this interaction reduced CLDN18 ubiquitination, thereby promoting protein expression. Finally, western blot and immunofluorescence assays confirmed that LINC01547-ORF could target CLDN18 to inhibit the FAK/PI3K/AKT signaling pathway, suppressing colorectal cancer cell development. These findings suggest that the LINC01547-ORF-encoded small protein inhibits proliferation and migration in colorectal cancer, thereby offering a promising direction for treating this disease.

摘要

长链非编码RNA(lncRNA)编码的小蛋白在结直肠癌中起主要作用。为了鉴定更多具有功能的编码小蛋白,对来自结直肠癌细胞的核糖体分析数据进行筛选,以寻找与核糖体相关的lncRNA。该筛选鉴定出LINC01547,它被证明可编码一种由76个氨基酸组成的小蛋白,称为LINC01547-ORF。实时定量荧光显示,LINC01547在结直肠癌组织中的表达下调。然而,细胞功能实验表明,LINC01547抑制了结直肠癌细胞系的增殖和迁移。同时,蛋白质印迹和免疫荧光实验证实LINC01547编码LINC01547-ORF。细胞功能实验表明,与LINC01547本身相比,LINC01547-ORF抑制了结直肠癌细胞系的增殖和迁移。基因集富集分析确定了粘着斑通路中的富集以及与CLDN18蛋白的关联,而蛋白质分子对接模型揭示了相互作用结构域和氨基酸残基位点。值得注意的是,免疫共沉淀和免疫荧光实验表明,LINC01547-ORF可与CLDN18蛋白结合,这种相互作用减少了CLDN18的泛素化,从而促进了蛋白表达。最后,蛋白质印迹和免疫荧光实验证实,LINC01547-ORF可靶向CLDN18以抑制FAK/PI3K/AKT信号通路,从而抑制结直肠癌细胞的发展。这些发现表明,LINC01547-ORF编码的小蛋白可抑制结直肠癌的增殖和迁移,从而为治疗这种疾病提供了一个有前景的方向。

相似文献

1
The small protein LINC01547-ORF inhibits colorectal cancer progression by regulating the CLDN18-FAK-AKT axis.
Am J Cancer Res. 2024 Nov 15;14(11):5504-5520. doi: 10.62347/PNKH7683. eCollection 2024.
6
The Novel LncRNA WASH5P Inhibits Colorectal Cancer Carcinogenesis Targeting AKT Signaling Pathway.
Front Oncol. 2022 Jul 11;12:923425. doi: 10.3389/fonc.2022.923425. eCollection 2022.
8
LncRNA AB073614 regulates proliferation and metastasis of colorectal cancer cells via the PI3K/AKT signaling pathway.
Biomed Pharmacother. 2017 Sep;93:1230-1237. doi: 10.1016/j.biopha.2017.07.024. Epub 2017 Jul 20.
9
BVES-AS1 suppresses the colorectal cancer progression via the miR-1269a/b-SVEP1-PI3K/AKT axis.
Adv Clin Exp Med. 2024 Nov;33(11):1217-1236. doi: 10.17219/acem/175050.

本文引用的文献

3
The microbial landscape of colorectal cancer.
Nat Rev Microbiol. 2024 Apr;22(4):240-254. doi: 10.1038/s41579-023-00973-4. Epub 2023 Oct 4.
4
Distinct regulatory functions and biological roles of lncRNA splice variants.
Mol Ther Nucleic Acids. 2023 Mar 15;32:127-143. doi: 10.1016/j.omtn.2023.03.004. eCollection 2023 Jun 13.
5
Jianpi Yangzheng decoction suppresses gastric cancer progression via modulating the miR-448/CLDN18.2 mediated YAP/TAZ signaling.
J Ethnopharmacol. 2023 Jul 15;311:116450. doi: 10.1016/j.jep.2023.116450. Epub 2023 Apr 5.
6
Targeting CLDN18.2 in cancers of the gastrointestinal tract: New drugs and new indications.
Front Oncol. 2023 Mar 10;13:1132319. doi: 10.3389/fonc.2023.1132319. eCollection 2023.
7
The ubiquitin ligase TRIM21 regulates mutant p53 accumulation and gain of function in cancer.
J Clin Invest. 2023 Mar 15;133(6):e164354. doi: 10.1172/JCI164354.
8
LINC00998-encoded micropeptide SMIM30 promotes the G1/S transition of cell cycle by regulating cytosolic calcium level.
Mol Oncol. 2023 May;17(5):901-916. doi: 10.1002/1878-0261.13358. Epub 2022 Dec 29.
10
Claudin18.2 is a novel molecular biomarker for tumor-targeted immunotherapy.
Biomark Res. 2022 May 31;10(1):38. doi: 10.1186/s40364-022-00385-1.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验